Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

Dexamethasone can cause side effects that range from mild to serious. More common side effects include fluid buildup and acne. If dexamethasone side effects become difficult to tolerate ...

Researchers in a new study has found that the administration of DXM after unilateral total knee arthroplasty (TKA) can ...

Corticosteroid therapy must be tapered because of its interactions with the hypothalamic-pituitary-adrenocortical (HPA) axis. The hypothalamus secretes corticotropin releasing factor, which acts ...

The FDA has sent its first untitled letter of 2025, hitting Edenbridge Pharmaceuticals with a notice after assessin | The FDA ...

New findings from researchers at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute could help make immunotherapies for brain cancer more effective. The team analyzed almost ...

Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S Group】, in collaboration with the Chinese Herbal Fungi Industry Research and Development Association (CHFIRDA), hosted the "Pharmacological ...

Dexamethasone 0.5mg, 0.75mg, 4mg, 6mg; tabs. Naturally occurring glucocorticoids, (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in ...

Sanofi's Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and Welfare for use in conjunction with bortezomib, lenalidomide and dexamethasone (VRd) to treat adults with ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...